Search Pages
PrintPrint EmailEmail
James A Underberg

Biosketch / Results /

James A Underberg, M.D.

Clinical Assistant Professor;
Department of Medicine (GIM Div)

Clinical Addresses

317 EAST 34 STREET, 7 FLOOR
NEW YORK, NY 10016
Hours: Mon. 1 - 7; Tue. 10 - 7; Wed. 8 - 5; Thu. 10 - 8; Fri. 8 - 3
Phone: 212-726-7430
Fax: 212-209-3236

« Back to Results

Medical Specialties

Internal Medicine

Medical Expertise

Preventive Medicine, Preventive Cardiology, Cholesterol & Lipids

Clinical Responsibilities

Dr. Underberg is a Clinical Assistant Professor of Medicine in the Division of General Internal Medicine at NYU Medical School and is a member of the executive committee of the Division of General Internal Medicine. His clinical focus is Preventive Cardiovascular Medicine. He is an American Society of Hypertension Certified Specialist in Clinical Hypertension, a fellow of the Society for Vascular Medicine & Biology, and a North American Menopause Society Certified Menopause Practitioner. Dr. Underberg is the founder and President of the New York Preventive Cardiovascular Society and a member of the Board of Directors of the Northeast Chapter of the National Lipid Association. He graduated from Yale University with a BS and MS and from the University of Pennsylvania Medical School. His internship and residency were completed at Bellevue Hospital Medical Center. He is currently involved in several clinical trials in the areas of hypertension, lipids, diabetes and cardiovascular disease. Dr. Underberg?s Clinical Practice was recently awarded recognition by the American Heart Association/American Stroke Association and the National Committee for Quality Assurance Heart-Stroke Recognition Program and the American Diabetes Association Diabetes Prevention Program. He sees patients both in his private referral practice and in the Bellevue Hospital Lipid Clinic.

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO, Cigna HMO/POS, Cigna PPO, MULTIPLAN/PHCS PPO, OXFORD FREEDOM, UHC EPO, UHC HMO, UHC POS, UHC PPO, UHC TOP TIER

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2001 — Internal Medicine

Education

1982-1986 — Univ. of Pennsylvania School of Medicine, Medical Education
1986-1989 — NYU Medical Center (Internal Medicine), Residency Training

« Back to Results

Research Interests

Hypertension, Lipidology, Insulin resistance and Metabolic Syndrome

Research Keywords

Hypertension, Lipidology, Insulin resistance and Metabolic Syndrome

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search#about

Resistant hypertension and sleep apnea: pathophysiologic insights and strategic management
Williams, Stephen K; Ravenell, Joseph; Jean-Louis, Girardin; Zizi, Ferdinand; Underberg, James A; McFarlane, Samy I; Ogedegbe, Gbenga
2011 Feb;11(1):64-69, Current diabetes reports
Resistant hypertension is common among adults with hypertension affecting up to 30% of patients. The treatment of resistant hypertension is important because suboptimal blood pressure control is the leading preventable cause of death worldwide. A frequent comorbid condition in patients with resistant hypertension is obstructive sleep apnea. The pathophysiology of sleep apnea-associated hypertension is characterized by sustained adrenergic activation and volume retention often posing treatment challenges in patients with resistant hypertension. This review will address some of the epidemiologic data associating apnea with the pathogenesis of resistant hypertension. Diagnosis and management of apnea and its associated hypertension will also be considered
— id: 138271, year: 2011, vol: 11, page: 64, stat: Journal Article,

ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association
Bairey Merz, C Noel; Alberts, Mark J; Balady, Gary J; Ballantyne, Christie M; Berra, Kathy; Black, Henry R; Blumenthal, Roger S; Davidson, Michael H; Fazio, Sara B; Ferdinand, Keith C; Fine, Lawrence J; Fonseca, Vivian; Franklin, Barry A; McBride, Patrick E; Mensah, George A; Merli, Geno J; O'Gara, Patrick T; Thompson, Paul D; Underberg, James A
2009 Sep 29;120(13):e100-e126, Circulation
— id: 109383, year: 2009, vol: 120, page: e100, stat: Journal Article,

ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association
Bairey Merz, C Noel; Alberts, Mark J; Balady, Gary J; Ballantyne, Christie M; Berra, Kathy; Black, Henry R; Blumenthal, Roger S; Davidson, Michael H; Fazio, Sara B; Ferdinand, Keith C; Fine, Lawrence J; Fonseca, Vivian; Franklin, Barry A; McBride, Patrick E; Mensah, George A; Merli, Geno J; O'Gara, Patrick T; Thompson, Paul D; Underberg, James A
2009 Sep 29;54(14):1336-1363, Journal of the American College of Cardiology
— id: 109385, year: 2009, vol: 54, page: 1336, stat: Journal Article,

Utility of different lipid measures to predict coronary heart disease
Remick, Joshua; Underberg, James A; Shah, Nirav R
2008 Jan 2;299(1):35-36, JAMA
— id: 93985, year: 2008, vol: 299, page: 35, stat: Journal Article,

Targeting high-density lipoprotein cholesterol in diabetic patients to reduce cardiovascular risk
Underberg J.A.; Shah N.R.
2007 ;14(9):486-487, Journal of Clinical Outcomes Management
— id: 74410, year: 2007, vol: 14, page: 486, stat: Journal Article,

Bridging the gap in treatment options for patients with hypertriglyceridemia
Underberg, James A; Hays, Richard
2007 Dec;56(12 Suppl New):S24-S31, Journal of family practice
Hypertriglyceridemia is a commonly encountered problem in primary care practice. In 2002, the Third National Health and Nutrition Examination Survey reported that among adults 20 years of age and older, 30% had a triglyceride (TG) level greater than 150 mg/dL, and among people 50 years of age and older, the prevalence was 42.8%. Recent data suggest that elevated TG levels are an independent risk factor for cardiovascular disease (CVD). It is important, therefore, that clinicians identify patients with hypertriglyceridemia and initiate treatment as appropriate. In this article, we use a case study to illustrate the appropriate identification and treatment of a patient at risk. We also review the etiology of hypertriglyceridemia, its association with CVD, the recommended approach to treatment, and the efficacy and tolerability of therapeutic options
— id: 93984, year: 2007, vol: 56, page: S24, stat: Journal Article,